Company / Operating Cash Flow
TREACE MEDICAL CONCEPTS, INC. Operating Cash Flow History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow
-$34.6M
FY2025
5-year range
-$34.6M / -$4.5M
FY2021-FY2025
Trend
-12.8%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Cash Flow has declined for 3 consecutive years, from -$4M in FY2022 to -$35M in FY2025.
Based on SEC 10-K filings.
-$35M in FY2025.
Declined from -$17M to -$35M over the past 2 years.
Operating Cash Flow over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- TREACE MEDICAL CONCEPTS, INC.'s operating cash flow has declined for 3 consecutive years.
- In FY2025, operating cash flow decreased 12.8% year-over-year.
- Peak operating cash flow was recorded in FY2022.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 1.13 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$34.6M | -12.8% |
| FY2024 | -$30.6M | -78.3% |
| FY2023 | -$17.2M | -282.6% |
| FY2022 | -$4.5M | +41.4% |
| FY2021 | -$7.7M | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026